Materialise NV

Materialise NV is engaged in the provision of additive manufacturing software and 3D printing services. It operates through the following segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software worldwide through programs and platforms that enable companies to set up reliable and sustainable 3D printing production. The Materialise Medical segment includes medical software solutions, medical devices and other related products and services. The Materialise Manufacturing segment provides 3D printed services to industrial and commercial customers. The company was founded by Wilfried Vancraen and Hilde Ingelaere on June 28, 1990 and is headquartered in Leuven, Belgium.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Materialise NV reports strong revenue growth and strategic investments

Materialise NV's Q4 2022 earnings call highlighted solid revenue growth, operational achievements, and strategic investments in key segments.
While facing challenges in the software segment and increased costs, the company remains focused on growth and innovation.
With a positive financial outlook for 2023, Materialise NV is poised for continued expansion and profitability, leveraging opportunities for market growth and operational improvements.

Materialise NV reports robust Q1 earnings amidst leadership transition

Materialise NV delivered a strong performance in Q1 2023, demonstrating growth across segments and highlighting its resilience and strategic focus on innovation and partnerships.
While facing challenges such as operational concerns and leadership transitions, the company remains well-positioned to leverage opportunities in the medical and manufacturing sectors for sustainable growth.
Investors should monitor Materialise's ability to navigate challenges, capitalize on opportunities, and maintain its competitive edge through strategic initiatives and market expansion efforts.

Materialise NV reports Q2 growth, navigates challenges, eyes future opportunities

Materialise NV's Q2 performance showcased revenue growth, operational improvements, and resilience in maintaining revenue guidance amidst challenges.
The company's strengths in 3D printing technology, cost management, and strategic focus position it well for future growth opportunities.
Challenges like the adverse arbitration impact and economic uncertainties highlight the need for strategic management and operational optimization to drive profitability and sustainable growth.

Materialise NV reports Q3 growth, focuses on medical device market

Materialise NV maintains full-year revenue guidance of EUR 255-260 million and adjusted EBITDA guidance of EUR 28-33 million. New CEO Brigitte de Vet-Veithen introduced to lead the company through evolving market dynamics.

Materialise NV reports robust Q4 performance and optimistic 2024 outlook

Materialise NV's Q4 2023 earnings call showcases strong financial performance, strategic initiatives, and a positive outlook for 2024
The company's focus on medical applications, software partnerships, and manufacturing services positions it for future growth
While facing market challenges and analyst inquiries, Materialise remains optimistic about its growth trajectory and market opportunities

Materialise NV reports mixed Q1 results, eyes growth opportunities

Materialise NV's Q1 2024 performance reflected revenue decline, offset by improved gross margin and net profit, with strategic priorities focused on growth areas.
The company showcased strengths in revenue growth, gross margin improvement, and increased net income, driven by software and medical segment demand.
Challenges in manufacturing and software segments were noted, along with increased operating expenses impacting profitability in the short term.
Opportunities lie in leveraging new technologies, market expansion, and innovation to drive future growth and capitalize on strong financial positioning.

Materialise NV reports robust Q3 results, eyes sustained growth

Materialise NV's Q3 2024 performance showcased strong revenue growth and profitability across segments, with the Medical segment leading the way.
The company's cash position and maintained guidance reflect stability and confidence in future prospects.
While facing challenges in manufacturing, Materialise NV is well-positioned to capitalize on opportunities for growth and innovation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Materialise NV engages in the provision of additive manufacturing software and 3D printing services. It operates through the following segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software worldwide through programs and platforms that enable companies to set up reliable and sustainable 3D printing production. The Materialise Medical segment includes medical software solutions, medical devices and other related products and services. The Materialise Manufacturing segment provides 3D printed services to industrial and commercial customers. The company was founded by Wilfried Vancraen and Hilde Ingelaere on June 28, 1990 and is headquartered in Leuven, Belgium.

Materialise continues to grow on the back of its Medical segment, which is expanding at a rapid pace. Materialise's margins will continue to improve going forward, driven by a combination of revenue mix and economies of scale. The ACTech plant expansion will provide a material tailwind in 2025, although disruptions wrought by its startup are likely to negatively impact fourth quarter revenue.

Materialise: Strong Q3 Results Despite Ongoing Market Headwinds

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Materialise (MTLS) Right Now?

Materialise (MTLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

What Makes Materialise (MTLS) a New Buy Stock

Materialise NV is a Belgian additive manufacturing company, showing a 14.18% CAGR in its Medical segment from FY18 to FY23. Despite mixed results in other segments, Materialise maintains profitability with positive FCF and a strong balance sheet, supported by €63 million in net cash. The company's strategic positioning in high-value sectors and steady growth, combined with a net cash position and positive FCF, highlight its upside potential.

Materialise: Medical Business Unit Is The Hidden Value

Materialise NV (NASDAQ:MTLS ) Q3 2024 Earnings Conference Call October 24, 2024 8:30 AM ET Company Participants Harriet Fried - Investor Relations-Lippert/Heilshorn & Associates Brigitte de Vet-Veithen - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Troy Jensen - Cantor Fitzgerald Alexander Kramer - Kepler Cheuvreux Jacob Stephan - Lake Street Capital Markets Operator Good day, and thank you for standing by. Welcome to the Q3 2024 Materialise Financial Results Conference Call.

Materialise NV (MTLS) Q3 2024 Earnings Call Transcript

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the third quarter ended September 30, 2024. Highlights – Third Quarter 2024 Total revenue increased 14.2% to 68,652 kEUR compared to 60,130 kEUR for the third quarter of 2023. Gross profit as a percentage of revenue for the third quarter of 2024 was 57.2%, compared to 56.0% for the t.

Materialise Reports Third Quarter 2024 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the third quarter ended September 30, 2024 on Thursday, October 24, 2024 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the third quarter 2024 financial results on Thursday, October 24, 2024 at 8:30 a.m. ET/2:30 p.m. CET. To access the.

Materialise NV to Report Third Quarter 2024 Earnings on Thursday, October 24, 2024

Materialise NV continues to face headwinds from soft prototyping demand and muted 3D printer sales. Despite this, Materialise reported solid Q2 results, with growth improving sharply. Recent acquisitions, new software launches, and expanded manufacturing capacity are expected to drive growth going forward.

Materialise Stock: Nearing An Inflection Point (Rating Upgrade)

Materialise NV (NASDAQ:MTLS ) Q2 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Harriet Fried - Investor Relations-Lippert/Heilshorn & Associates Brigitte de Vet - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Troy Jensen - Cantor Fitzgerald Jacob Stephan - Lake Street Capital Markets Operator Good day, and thank you for standing by. Welcome to the Q2 2024 Materialise Financial Results Conference Call.

Materialise NV (MTLS) Q2 2024 Earnings Call Transcript

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the second quarter ended June 30, 2024. Highlights – Second Quarter 2024 Total revenue increased 6.2% to 68,797 kEUR compared to 64,810 kEUR for the second quarter of 2023. Gross profit as a percentage of revenue for the second quarter of 2024 was 57.0%, in line with 57.2% for the co.

Materialise Reports Second Quarter 2024 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the second quarter ended June 30, 2024 on Wednesday, July 31, 2024 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the second quarter 2024 financial results on Wednesday, July 31 2024, at 8:30 a.m. ET/2:30 p.m. CET. To access the call by.

Materialise NV to Report Second Quarter 2024 Earnings on Wednesday, July 31, 2024

Is Materialise (MTLS) Stock Undervalued Right Now?

3D Systems

Every forward-thinking investor is considering 3D printing stocks. The growing use of the technology in industries such as aerospace, automotive, healthcare and consumer items led to a $22 billion industry in 2023, estimated to expand 24% to $150 billion by 2032 from $28 billion in 2024.

Rag to Riches: 3 3D Printing Stocks That Could Make Patient Investors Rich

Ardelyx

Sera Prognostics

Buying stocks that can make you millions is any investor's dream. That is why some investors consider micro-cap or small-cap stocks trading under $10.

3 Stocks Under $10 With the Potential to Make You a Millionaire

LEUVEN, Belgium, May 22, 2024 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders' Meeting at 10:00 am CEST on Tuesday, June 4, 2024.

Materialise to Hold Annual Shareholders' Meeting on June 4, 2024

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2024. Highlights – First Quarter 2024 Total revenue decreased by 3.4% to 63,637 kEUR compared to 65,886 kEUR for the first quarter of 2023. Gross profit as a percentage of revenue increased to 56.5% for the first quarter of 2024 from 55.9% for the 20.

Materialise Reports First Quarter 2024 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the first quarter ended March 31, 2024 on Thursday, April 25, 2024 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the first quarter 2024 financial results on Thursday, April 25, 2024, at 8:30 a.m. ET/2:30 p.m. CET. To access the call by.

Materialise NV to Report First Quarter 2024 Earnings on Thursday, April 25, 2024

The demand environment continues to weigh on Materialise's business, although the Medical segment remains a standout, with strong growth and improving margins. The adoption of robotics in joint replacement surgeries poses a threat to Materialise's medical business, though. Investments in the CO-AM platform and the ACTech facility expansion should begin to pay off in 2024, supporting growth and Materialise's competitive position.

Materialise: Upside From A Transition To Profitability

Materialise NV (NASDAQ:MTLS) Q4 2023 Earnings Conference Call February 21, 2024 8:30 AM ET

Materialise NV (MTLS) Q4 2023 Earnings Call Transcript

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of sophisticated 3D printing services, today announced its financial results for the fourth quarter and full year ended December 31, 2023. Highlights – Fourth Quarter 2023 Total revenue increased 4.1% to 65,295 kEUR for the fourth quarter of 2023 from 62,703 kEUR for the corresponding 2022 period. Total deferred revenues from software maintenance and li.

Materialise Reports Fourth Quarter and Full Year 2023 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the fourth quarter ended December 31, 2023 on Wednesday, February 21, 2024 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2023 financial results on Wednesday, February 21, 2024, at 8:30 a.m. ET/2:30 p.m. CET. To acces.

Materialise NV to Report Fourth Quarter 2023 Earnings on Wednesday, February 21, 2024

Materialise NV currently exhibits better growth, margins and fundamentals than its main competitors, positioning itself well in an industry that is estimated to grow at a CAGR of 16% until 2032; The medical business unit (c.a. 38.5% of total revenues in 9M23) continues to achieve double-digit growth, with the appointment of the new CEO to focus strongly on this segment; Both the analysis of multiples and DCF here presented show that the current share valuation is 40-45% below its fundamental value.

Materialise NV: Consolidation And New Developments To Emerge As A Rising Star In The Additive Manufacturing Industry

Blade Air Mobility

Opera Ltd - ADR

Tech has been the runaway success story of investing for years now. Even with increased volatility, no other sector has quite matched big tech's ability to deliver outsized returns over the long-run.

3 Tech Stocks That Analysts Think Will Double by December

Materialise reported soft Q3 results, but the stock responded positively anyway, indicating how negative sentiment had become. Weak demand in the Manufacturing segment is a drag, but the Software and Medical segments are still holding up. Macro headwinds are likely to be an ongoing issue, but Materialise's valuation is low. Both relative to peers and based on the company's ability to generate cash.

Materialise: Positive Response To Poor Results

Materialise NV (NASDAQ:MTLS ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Harriet Fried - LHA Peter Leys - Executive Chairman Koen Berges - CFO Wilfried Vancraen - Founder, CEO & Director Brigitte de Vet - Incoming CEO Conference Call Participants Jacob Stephan - Lake Street Capital Markets Troy Jensen - Lake Street Capital Markets Operator Good day, and thank you for standing by. Welcome to the Q3 2023 Materialise Financial Results Conference Call.

News for Materialise NV Stock (MTLS)